Subchondral bone marrow

Subchondral bone marrow refers to the specialized tissue located immediately beneath the subchondral bone plate in synovial joints. It serves as a vital metabolic unit that maintains joint integrity through mechanical load distribution and bidirectional biochemical crosstalk with the overlying articular cartilage [Source: NIH, PubMed PMID: 23146443]. In the context of joint diseases like osteoarthritis, the subchondral bone marrow undergoes significant structural changes, often manifesting as bone marrow lesions (BMLs) on magnetic resonance imaging (MRI), which are associated with pain and disease progression [Source: PubMed, PMID: 11566002]. While not a specific molecular target like a receptor or enzyme, it is a primary therapeutic site for bone-modifying agents such as bisphosphonates and RANKL inhibitors, which aim to modulate the abnormal bone turnover associated with cartilage degeneration. Recent research also focuses on regenerative approaches, including the delivery of mesenchymal stem cells directly into the subchondral marrow to promote tissue repair and reduce inflammation [Source: PubMed, PMID: 31057635].

Other names

Subchondral marrowEpiphyseal bone marrowSubchondral bone marrow space

Drugs targeting this region typically work by inhibiting osteoclast-mediated bone resorption (e.g., bisphosphonates, RANKL inhibitors) or stimulating osteoblast-mediated bone formation to resolve bone marrow lesions and stabilize the subchondral bone plate [Source: PubMed, PMID: 22441913].